NTRK1 and cancer: However, aberrant EGFR signaling can lead to epithelial transformation, making it one of the most studied tyrosine kinase receptors in cancer.220 Despite the clinical efficacy demonstrated by various EGFR-targeted therapies, acquired resistance often limits long-term effectiveness in cancer treatment.